An Observational Study of the Use and Safety of Raptiva During Pregnancy (FOLLOW)

RESTORE: Raptiva® (Efalizumab) Evaluation of Safety and Treatment Optimization

NCT00402818 ·Status: TERMINATED

Study of the Drug Efalizumab (Raptiva), for Adult Patients With Moderate to Severe Plaque Psoriasis

NCT00115076 ·Status: COMPLETED ·Phase: PHASE3

Evaluate Whether Combination Therapy With Methotrexate and Raptiva in Psoriasis Patients is Safe and Increases Efficacy

NCT00368654 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

ChangE From Any Systemic psoriasiS therapY to Raptiva

NCT00697593 ·Status: TERMINATED ·Phase: PHASE4

A Study to Evaluate Raptiva in Adults With Plaque Psoriasis Previously Enrolled in Study ACD2390g

NCT00109252 ·Status: COMPLETED ·Phase: PHASE3

A Study to Evaluate Psoriasis Outcomes and Safety Events in Patients With Chronic Moderate to Severe Plaque Psoriasis (RESPONSE)

NCT00096928 ·Status: COMPLETED

A Study to Evaluate the Effects of Efalizumab on Immune Responses in Subjects With Moderate Plaque Psoriasis

NCT00382512 ·Status: COMPLETED ·Phase: PHASE1

A Safety and Efficacy Study to Evaluate Efalizumab in Combination With UVB for Moderate to Severe Psoriasis

NCT00302445 ·Status: COMPLETED ·Phase: PHASE4

Genomic Study for the Prediction of Efficacy and Adverse Effects of CD11a Monoclonal Antibodies(Raptiva)

NCT00602823 ·Status: COMPLETED

A Safety Study of LY3462817 and LY3509754 in Participants With Psoriasis

NCT04152382 ·Status: TERMINATED ·Phase: PHASE1

TRUST Study: Raptiva ® in Hand & Foot Psoriasis

NCT00739882 ·Status: TERMINATED ·Phase: PHASE4

A Real-world Observational Study to Compare Effectiveness of Deucravacitinib Vs Apremilast in Adults With Plaque Psoriasis

NCT05744466 ·Status: RECRUITING

A Study to Evaluate the Efficacy and Safety of PF-06700841 in Subjects With Active Psoriatic Arthritis

NCT03963401 ·Status: COMPLETED ·Phase: PHASE2

Study Evaluating Enbrel (Etanercept) in Adult Patients With Plaque Psoriasis

NCT00227240 ·Status: COMPLETED

Therapeutic Drug Monitoring of Risankizumab in Psoriasis Patients (BIOLOPTIM-RIS)

NCT05685940 ·Status: RECRUITING ·Phase: PHASE4

A Study to Determine the Efficacy and Safety of Deucravacitinib Compared With Placebo in Participants With Active Psoriatic Arthritis (PsA) Who Are Naïve to Biologic Disease Modifying Anti-rheumatic Drugs or Had Previously Received TNFα Inhibitor Treatment

NCT04908189 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

An Observational Study of the Real Life Management of the Psoriasis Patients Treated With Enbrel According to the New Reimbursement Criteria

NCT01557283 ·Status: COMPLETED

Efficacy and Safety of HS-10374 Compared to Placebo in Adults With Active Psoriatic Arthritis

NCT06176508 ·Status: RECRUITING ·Phase: PHASE2

Study of Psoriatic Arthritis

NCT00001420 ·Status: COMPLETED

Comparison of CHS-0214 to Enbrel (Etanercept) in Patients With Chronic Plaque Psoriasis (PsO)

NCT02134210 ·Status: COMPLETED ·Phase: PHASE3

An Observational Study to Assess Change in Disease Activity and Treatment Patterns of Upadacitinib When Given Alone or Co-Administered With Methotrexate in Adult Participants With Active Psoriatic Arthritis

NCT05616871 ·Status: ACTIVE_NOT_RECRUITING

A Study to Evaluate Efalizumab in Adults With Plaque Psoriasis, Including Those Who Are Receiving Concomitant Antipsoriatic Therapies

NCT00338143 ·Status: COMPLETED ·Phase: PHASE3

Observational Study of Patients With Moderate to Severe Chronic Plaque Psoriasis

NCT03982394 ·Status: COMPLETED

Safety and Efficacy of Abatacept Versus Placebo in Participants With Psoriatic Arthritis

NCT00534313 ·Status: TERMINATED ·Phase: PHASE2

Evaluation of IL 12B Genetic Polymorphism (rs3213094)

NCT07128472 ·Status: RECRUITING ·Phase: NA